Phase III intergroup study of lenalidomide (CC-5013) versus placebo maintenance therapy following single autologous stem cell transplant for multiple myeloma (CALGB 100104): Initial report of patient accrual and adverse events
- Citation:
- J Clin Oncol vol 28 (15s) Poster Board III-353
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 247
- Program:
- OGC
- Primary Committee:
- Transplant
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- P. L. Mccarthy C. Linker C. C. Hofmeister K. Owzar E. Stadtmauer K. C. Anderson P. Richardson D. D. Hurd D. J. Weisdorf
- Networks:
- Study
- CALGB-100104
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: